Optic Neuritis Latest Advances

miRNA-34b overexpression alleviates neuromyelitis optica spectrum disorders by regulating the TIA-1-stress granule pathway.

Journal: Pakistan journal of pharmaceutical sciences

Published: September 08, 2026

Simulating Partial Conduction Delays in VEPs Via Asynchronous and Contrast-Modulated Stimulation.

Journal: Translational vision science & technology

Published: September 08, 2026

Corrigendum to "Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study" [Multiple Sclerosis and Related Disorders, Volume 97 (2025): 106383].

Journal: Multiple sclerosis and related disorders

Published: September 07, 2026

Life-threatening multisystem sarcoidosis with neurological, renal, ocular and autoimmune haemolytic manifestations treated with intravenous immunoglobulin, plasma exchange, cyclophosphamide and infliximab.

Journal: BMJ case reports

Published: September 04, 2026

A Pilot Study to Compare a Portable Tablet Perimeter with Humphrey Field Analyzer in Patients with Neuro-Ophthalmic Disorders.

Journal: Journal of binocular vision and ocular motility

Published: September 02, 2026

Guide to approaching the first demyelinating event in pediatrics

Journal: Medicina

Published: August 27, 2026

Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents

Journal: Medicina

Published: August 27, 2026

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

Journal: Neurology

Published: August 26, 2026

Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models.

Journal: Science translational medicine

Published: August 26, 2026

2,6-diaminopurine enhances Aqp4 stop codon readthrough and AQP4 perivascular localization in the brain.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Clinical Characteristics and Visual Outcomes of Optic Neuritis in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: August 17, 2026

Diagnosis of syphilitic chorioretinopathy in a patient with a history of relapsing-remitting multiple sclerosis and previous optic neuritis.

Journal: BMJ case reports

Published: August 13, 2026

Optic Neuritis Latest Advances

Find the Latest Research About Optic Neuritis

miRNA-34b overexpression alleviates neuromyelitis optica spectrum disorders by regulating the TIA-1-stress granule pathway.

miRNA-34b overexpression alleviates neuromyelitis optica spectrum disorders by regulating the TIA-1-stress granule pathway.

Simulating Partial Conduction Delays in VEPs Via Asynchronous and Contrast-Modulated Stimulation.

Simulating Partial Conduction Delays in VEPs Via Asynchronous and Contrast-Modulated Stimulation.

Corrigendum to "Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study" [Multiple Sclerosis and Related Disorders, Volume 97 (2025): 106383].

Corrigendum to "Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study" [Multiple Sclerosis and Related Disorders, Volume 97 (2025): 106383].

Life-threatening multisystem sarcoidosis with neurological, renal, ocular and autoimmune haemolytic manifestations treated with intravenous immunoglobulin, plasma exchange, cyclophosphamide and infliximab.

Life-threatening multisystem sarcoidosis with neurological, renal, ocular and autoimmune haemolytic manifestations treated with intravenous immunoglobulin, plasma exchange, cyclophosphamide and infliximab.

A Pilot Study to Compare a Portable Tablet Perimeter with Humphrey Field Analyzer in Patients with Neuro-Ophthalmic Disorders.

A Pilot Study to Compare a Portable Tablet Perimeter with Humphrey Field Analyzer in Patients with Neuro-Ophthalmic Disorders.

Guide to approaching the first demyelinating event in pediatrics

Guide to approaching the first demyelinating event in pediatrics

Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents

Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models.

Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models.

2,6-diaminopurine enhances Aqp4 stop codon readthrough and AQP4 perivascular localization in the brain.

2,6-diaminopurine enhances Aqp4 stop codon readthrough and AQP4 perivascular localization in the brain.

Clinical Characteristics and Visual Outcomes of Optic Neuritis in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Clinical Characteristics and Visual Outcomes of Optic Neuritis in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Diagnosis of syphilitic chorioretinopathy in a patient with a history of relapsing-remitting multiple sclerosis and previous optic neuritis.

Diagnosis of syphilitic chorioretinopathy in a patient with a history of relapsing-remitting multiple sclerosis and previous optic neuritis.